Sparing radiation-induced damage to the physis by radioprotectant drugs: Laboratory analysis in a rat model

Journal of Orthopaedic Research

Volumn 17, Issue 2, 1999, Pages 286-292

  Tamurian, R M ^a   Damron, T A ^a   Spadaro, J A ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; IONIZING RADIATION; RADIATION DAMAGE; RADIOTHERAPY;

LABORATORY ANALYSIS; PHYSIS; RADIOPROTECTANT DRUGS; RAT MODEL;

JOINTS (ANATOMY);

AMIFOSTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE INJURY; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FEMUR; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIATION PROTECTION; RAT; TIBIA;

AMIFOSTINE; ANIMALS; BONE DEVELOPMENT; DISEASE MODELS, ANIMAL; FEMUR; GROWTH PLATE; HINDLIMB; PILOT PROJECTS; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TIBIA; X-RAYS;

EID: 0032933684     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100170219     Document Type: Article

References (45)

1. Albanese SA, Spadaro JA, Chase SE, Geel CW: Bone growth after osteotomy and internal fixation in young rabbits. J Orthop Res 14:921-926, 1996
2. Billen D: The effects of radioprotectors on DNA polymerase I-directed repair synthesis and DNA strand breaks in toluene-treated and X-irradiated Escherichia coli. Radiat Res 95:158-164, 1983
3. Bogo V, Jacobs AJ, Weiss JF: Behavioral toxicity and efficacy of WR-2721 as a radioprotectant. Radiat Res 104:182-190, 1985
4. Brighton CT: The growth plate. Orthop Clin North Am 15:571-595, 1984
5. Brown PE: Mechanism of action of aminothiol radioprotectors. Nature 213:363-364, 1967
6. Chan JYH, Stout DL, Becker FF: Protective role of thiols in carcinogen-induced DNA damage in rat liver. Carcinogenesis 7:1621-1624, 1986
7. Constine LS, Zagars G, Rubin P, Kligerman M: Protection by WR-2721 of human bone marrow function following irradiation. Int J Radiat Oncol Biol Phys 12:1505-1508, 1986
8. Damron TA, Pritchard DJ: Current combined treatment of high-grade osteosarcomas. Oncology 9:327-343, 1995
9. Damron TA, Sim FH, O'Connor MI, Pritchard DJ, Smithson WA: Ewing's sarcoma of the proximal femur. Clin Orthop 322:232-244, 1996
10. Damron TA: Endoprosthetic replacement following limb-sparing resection for bone sarcoma. Semin Surg Oncol 13:3-10, 1997
11. Delaney JP, Bonsack ME, Felemovicius I: Radioprotection of the rat small intestine with topical WR-2721. Cancer 74:2379-2384, 1994
12. Douay L, Hu C, Giarratana MC, Garin NC: Comparative effects of amifostine (Ethyol) on normal hematopoetic stem cells versus human leukemic cells during ex vivo purging in autologous bone marrow transplants. Semin Oncol 21:16-20, 1994
13. Eifel PJ: Decreased bone growth arrest in weanling rats with multiple radiation fractions per day. Int J Radiat Oncol Biol Phys 15:141-145, 1988
14. Eifel PJ, Sampson CM, Tucker SL: Radiation fractionation sensitivity of epiphyseal cartilage in a weanling rat model. Int J Radiat Oncol Biol Phys 19:661-664, 1990
15. Eifel PJ, Donaldson SS, Thomas PR: Response of growing bone to irradiation: a proposed late effects scoring system. Int J Radiat Oncol Biol Phys 31:1301-1307, 1995
16. Geng L, Hanson WR, Malkinson FD: Topical or systemic 16, 16 dm prostaglandin E2 or WR-2721 (WR-1605) protects mice from allopecia after fractionated irradiation. Int J Radiat Biol 61:533-537, 1992
17. Goldwein JW: Effects of radiation therapy on skeletal growth in childhood. Clin Orthop 262:101-107, 1991
18. Grdina DJ, Peraino C, Carnes BA, Hill CK: Protective effect of S-2-(3-aminopropylamino) ethylphosphorothioic acid against induction of altered hepatocyte foci in rats treated once with gamma-radiation within one day after birth. Cancer Res 45:5379-5381, 1985
19. Grdina DJ, Nagy B, Hill CK, Wells RL, Peraino C: The radioprotector WR1065 reduced radiation-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in V79 cells. Carcinogenesis 6:929-931, 1985
20. Grdina DJ, Sigdestad CP: Radiation protectors: the unexpected benefits. Drug Metab Rev 20:13-42, 1989
21. Herrera JL, Vigneulle RM, Gage T, MacVittie TJ, Nold JB, Dubois A: Effect of radiation and radioprotection on small intestinal function in canines. Dig Dis Sci 40:211-218, 1995
22. Hill CK, Nagy B, Peraino C, Grdina DJ: 2-[(Aminopropyl) amino]ethanethiol (WR1065) is anti-neoplastic and antimutagenic when given during 60Co gamma-ray irradiation. Carcinogenesis 7:665-668, 1986
23. Hinkel CL: The effect of roentgen rays upon the growing long bones of albino rats. II: Histopathological changes involving endochondral growth centers. AJR: Am J Roentgenol 49:321-348, 1943
24. Hinkel CL: The effect of irradiation upon the composition and vascularity of growing rat bones. AJR: Am J Roentgenol 50:516-526, 1943
25. Jagetia GC: Influence of chlorpromazine, bleomycin and WR-2721 singly or in combination on the formation of radiation-induced micronuclei in mice bone marrow. Strahlenther Onkol 170:648-653, 1994
26. 60Co gamma-rays in mice. Int J Radiat Biol 61:387-392, 1992
27. Kember NF: Cell survival and radiation damage in growth cartilage. Brit J Radiol 40:496-505, 1967
28. Kember NF, Coggins J: Changes in the vascular supply to rat growth cartilage during radiation injury and repair. Int J Radiol Biol 12:143-151, 1967
29. Kirkwood BR: Essentials of Medical Statistics. Oxford, Blackwell Scientific, 1988
30. Maisin JR, Mattelin G, Lambiet-Collier M: Chemical protection against the long-term effects of a single whole-body exposure of mice to ionizing radiation. I. Life shortening. Radiat Res 71:119-131, 1977
31. Maisin JR, Decleve A, Gerber GB, Mattelin G, Lambiet-Collier M: Chemical protection against the long-term effects of a single whole-body exposure of mice to ionizing radiation. II. Causes of death. Radiat Res 74:415-435, 1978
32. Milas L, Hunter N, Reid BO, Thames HD Jr: Protective effects of S-2-(3-aminopropylamino)-ethylphosphothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice. Cancer Res 42:1888-1897, 1982
33. Milas L, Hunter N, Stephens LC, Peters LJ: Inhibition of radiation carcinogensis in mice by S-2,3-aminopropylamino-ethylphosphothioic acid. Cancer Res 44:5567-5569, 1984
34. Probert JC, Parker BR: The effects of radiation therapy on bone growth. Radiology 114:155-162, 1975
35. Robertson WW Jr, Butler MS, D'Angio GJ, Rate WR: Leg length discrepancy following irradiation for childhood tumors. J Pediatr Orthop 11:284-287, 1991
36. Shaker JL, Fallon MD, Goldfarb S, Farber J, Attie MF: WR-2721 reduces bone loss after hindlimb tenotomy in rats. J Bone Miner Res 4:885-890, 1989
37. Spadaro JA, Skarulis T, Albanese SA: Effect of pulsed ultrasound on bone growth in rats. Trans Meet Soc Physical Reg In Biol Med 14:10, 1994
38. Takahashi S, Sugimoto M, Kotoura Y, Sasai K, Oka M, Yamamuro T: Long-term changes in the haversian systems following high-dose irradiation: an ultrastructural and quantitative histomorphological study. J Bone Joint Surg [Am] 76:722-738, 1994
39. Utley JF, Marlowe C, Waddell WJ: Distribution of 35 S-labeled WR-2721 in normal and malignant tissues of the mouse. Radiat Res 68:284-291, 1976
40. van der Vijgh WJ, Peters GJ: Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (Ethyol): preclinical aspects. Semin Oncol 21:2-7, 1994
41. Weiss J, Walker ST, Fallon M, Goldfarb S: In vivo and in vitro effects of WR-2721 in experimental hypercalcemia in the rat. J Pharmacol Exp Ther 238:969-973, 1986
42. Yuhas SM, Storer JB: Differential chemoprotection of normal and malignant tissues. J Natl Cancer Inst 42:331-335, 1969
43. Yuhas SM, Proctor JO, Smith LH: Some pharmacologic effects of WR-2721: their role in toxicity and radioprotection. Radiat Res 54:222-233, 1973
44. Yuhas SM: Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Res 40:1519-1524, 1980
45. Yuhas JM, Davis ME, Glover D, Brown DQ, Ritter M: Circumvention of the tumor membrane barrier to WR-2721 absorption by reduction of drug hydrophilicity. Int J Radiat Oncol Biol Phys 8:510-522, 1982